உலகளாவிய தடுப்பு மருந்துகள் பொறியியல் கோர் தொழில்நுட்பங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from உலகளாவிய தடுப்பு மருந்துகள் பொறியியல் கோர் தொழில்நுட்பங்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In உலகளாவிய தடுப்பு மருந்துகள் பொறியியல் கோர் தொழில்நுட்பங்கள் Today - Breaking & Trending Today

BiondVax Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update


BiondVax Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
USA - English
Share this article
JERUSALEM, May 13, 2021 /PRNewswire/
BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and ultimately commercializing products for the prevention and treatment of infectious diseases and related illnesses, today published its fourth quarter and full year financial results for the year ended December 31, 2020 and provided a business update.
Fourth Quarter 2020 Financial Summary
Results are in New Israel Shekels (NIS) and convenience translation to US$ is provided using the exchange rate of 3.215 (NIS/US$), the rate as of the close of business on December 31, 2020.  ....

Israel General , Joshuae Phillipson , Amir Reichman , Ron Babecoff , Exchange Commission , Company Annual Report On Form , Exchange Commission On , Prnewswire Biondvax Pharmaceuticals Ltd , Biondvax Pharmaceuticals Ltd , European Investment Bank , Vax Pharmaceuticals , New Israel Shekels , Global Vaccines Engineering Core Technologies , Asset Management , Senior Director Global , Kenny Green , Private Litigation Reform Act , Biondvax Pharmaceuticals , Annual Report , இஸ்ரேல் ஜநரல் , பரிமாற்றம் தரகு , நிறுவனம் ஆண்டு அறிக்கை ஆன் வடிவம் , பரிமாற்றம் தரகு ஆன் , ஐரோப்பிய முதலீடு வங்கி , வ்யாக்ஸ் மருந்துகள் , உலகளாவிய தடுப்பு மருந்துகள் பொறியியல் கோர் தொழில்நுட்பங்கள் ,

ADMP's Symjepi Hits Walgreen's Shelves, Eli Lilly's Antibody Cuts COVID-19 Risk By 80%, FLDM On Watch


(2)
INDIANAPOLIS (dpa-AFX) - Today s Daily Dose brings you news about the effectiveness of Lilly s Bamlanivimab in reducing the risk of contracting symptomatic COVID-19 among residents and staff of long-term care facilities, executive changes at BiondVax Pharma, regulatory update on Genetic Technologies COVID-19 PRS Test, Adamis SYMJEPI products being made available in the Walgreens Prescription Savings Club, Fluidigm s Advanta Dx SARS-CoV-2 RT-PCR Assay receiving the CE-IVD mark.
Read on.
1. Adamis to Offer SYMJEPI in Walgreens Prescription Savings Club
Adamis Pharmaceuticals Corporation (ADMP) surged more than 90% in after-hours Thursday, on news of its SYMJEPI products now being available to members of the Walgreens Prescription Savings Club program. ....

Biondvax Pharma , Lilly Bamlanivimab , Myron Cohen , Eli Lilly , Amir Reichman , Ron Babecoff , Celsion Corporation , Adamis Pharmaceuticals Corporation , Biondvax Pharmaceuticals Ltd , Obalon Therapeutics Inc , Medicaid Services Clinical Laboratory Improvement Amendments , Centers For Medicare , Cancer Genetics Inc , Walgreens Prescription Savings Club , University Of North Carolina At Chapel Hill , Rewalk Robotics Ltd , Genetic Technologies Limited , Fluidigm Corp , Corbus Pharmaceuticals Holdings Inc , Institute For Global Health , Daily Dose , Genetic Technologie , Walgreens Prescription Savings , Pharmaceuticals Corporation , Vax Ropes , Vax Pharmaceuticals ,